688117.SH
圣诺生物
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 24.20
−6.17%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
CNY 5.33B
MomentumView details →
1D Return
−6.17%
YTD Return
—
RSI (14)
38.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
CNY 5.33B
RSI (14)
38.3
MomentumView details →
1D Return
−6.17%
YTD Return
—
Similar companies
Latest newsMore news →
Shengnuo Biopharmaceutical's wholly-owned subsidiary Chengdu Shengnuo Biopharmaceutical received a drug registration certificate from China's National Medical Products Administration for linaclotide capsules (290μg), approving the product for market.1d agoSino Bio's wholly-owned subsidiary Chengdu Sino Bio Pharmaceutical received approval from China's National Medical Products Administration for the registration of its active pharmaceutical ingredient terlipressin acetate, packaged at 10g per bottle.8d ago